The strategic collaboration combines IQVIA’s clinical trial and regulatory infrastructure with Medera’s Sardocor and Novoheart platforms to support cardiac gene therapies, patient recruitment and human-based drug discovery.
verifying reliability
No specialized terms available for this topic.